Please enable JavaScript to view the site.

About Deloitte
Contact us
Location: Global

Services
What's New
Audit & Assurance

IASPlus

Consulting

Human Capital

Strategy & Operations

Technology

Risk Advisory

Strategic & Reputation Risk

Regulatory Risk

Financial Risk

Operational Risk

Cyber Risk
Financial Advisory

Mergers & Acquisitions

Financial Crisis

Legal

Deloitte Legal around the world

Dbriefs Legal

Deloitte Legal services

Tax

Global Business Tax

Global Employer Services

Global Tax Reset
Industries
What's New
Consumer

Automotive

Consumer Products

Retail, Wholesale & Distribution

Transportation, Hospitality & Services

Energy, Resources & Industrials

Industrial Products & Construction

Mining & Metals

Oil, Gas & Chemicals

Power & Utilities

Financial Services

Banking & Capital Markets

Insurance

Investment Management

Real Estate
Government & Public Services

Civil Government

Defense, Security & Justice

Health & Social Care

International Donor Organizations

Transport

Life Sciences & Health Care

Health Care

Life Sciences

Technology, Media & Telecommunications

Technology

Telecommunications, Media & Entertainment
Careers
What's New
- Millennial Survey 2018
  Millennials’ confidence in business, loyalty to employers deteriorate
- Alumni profiles
  Inspiring leaders
Job search

Experienced hires

Students

Life at Deloitte

Alumni

Life Sciences

Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's challenges. The DTTL network understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life.

Health Care
Life Sciences and Health Care home

All
Solutions
People

Article

Future of business interaction

A study on the interaction between MedTech companies and hospitals

With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.

Events

Financial Times Digital Health Summit USA

The event brings a fresh perspective to the digital health space as health care providers, pharmaceutical companies, medical device manufacturers, health insurers, and technology companies come together to discuss value-creating health care solutions, the changing pharma-patient relationship, and how regulations will drive this disruptive space.

Perspectives

A life sciences and health care perspective: Tech Trends 2018

Technology trends transforming the future of life sciences and health care

Events

Financial Times/Deloitte Global Pharmaceutical & Biotechnology Conference

This industry-leading event joins life sciences companies and their health care sector counterparts to review trends and opportunities for creating a successful life sciences economy. The event also features discussions of strategies to help companies thrive in an era of unparalleled disruption.

Article

EU Clinical Trial Regulation

Building a successful program

Deloitte Insights

The future of real-world evidence

A focus on end-to-end, AI-driven, internally developed solutions

Analysis

2018 Global life sciences outlook

Innovating life sciences in the fourth industrial revolution: Embrace, build, grow

The evolving industrialization of life sciences will affect all aspects of how companies work to meet consumer expectations. Learn more in the outlook for 2018.

Article

Time to care

Securing a future for the hospital workforce in Europe

In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.

Deloitte Insights

The right health care the right way

Global case studies in reducing low-value care

Billions of dollars are wasted annually in the United States on “low value” health care services such as unnecessary diagnostic tests, trips to the emergency room, and avoidable surgeries. Explore how some organizations globally are using innovative approaches and technologies to combat this issue.

Predictions

The future awakens

Life Sciences and Health Care Predictions 2022

The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.

Article

Identification of Medicinal Products

Connecting the parts

The potential benefits of meeting the evolving Identification of Medicinal Product (IDMP) requirements extend far beyond regulatory compliance. Learn more here.

Analysis

Pharma and the connected patient

How digital technology is enabling patient centricity

New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.

Article

A new future for R&D?

Measuring the return from pharmaceutical innovation 2017

Pharmaceutical innovation study by the Deloitte UK Centre for Health Solutions looks at the challenges the industry faces in generating returns from its R&D investments while highlighting the key strategies to help increase pipeline value while reduce R&D costs to generate sustainable R&D returns.

Article

Facing the tidal wave

De-risking pharma and creating value for patients

Article

The bigger picture

Impact of EU regulatory change on the global life sciences industry

Recent and ongoing European regulatory changes will impact every pharmaceutical, biotechnology or medical technology (medtech) company that currently sells or sponsors products in the European Union (EU).

Article

Regulation in Life Sciences

Turning complexity into opportunity

Stay ahead of the curve when it comes to regulatory policy in Life Sciences. Here you'll find a range of tools on a variety of topics from around the globe that provide critical insight and advice, helping you to anticipate change and plan ahead.

Article

High value, high uncertainty

Measuring risk in biopharmaceutical research and other industries

Article

Under the spotlight

Data integrity in life sciences

Regulatory bodies now have high expectations with regard to data quality and integrity owing to the life sciences industry’s growth, globalization and adoption of advanced technology, such as highly automated systems and storage of data in ‘The Cloud’. Read the report to learn more.

Article

2017 Pharmaceutical R&D leader survey

Innovating to survive, collaborating to thrive

Perspectives

Join the conversation

Social media connections to Deloitte's LSHC practice

Article

Unravelling complexity

The challenge of compliance in the life sciences supply chain

Article

Leadership perspectives

Insights on today’s hot topics in life sciences and health care

The Health Care Current, a weekly series published by the Deloitte US Center for Health Solutions, explores breaking news and developments in the health care industry, examines key issues facing LSHC companies and provides updates and insights on policy, regulatory, and legislative changes.

Analysis

M&A trends in life sciences and health care

Explore Deloitte survey findings on M&A trends in the life sciences and health care industry.

Article

Preparing for the future

The new European Union medical devices regulation

Article

The challenge of compliance

The life sciences industry faces unprecedented challenges amid increasing regulatory scrutiny. This latest Deloitte report explores the enterprise-wide compliance functions of major life science companies – identifying the big trends and opportunities to enable a move from cost to value.

Perspectives

Biosimilars in global markets

Analysts expect the worldwide biosimilars market to reach approximately $35 billion by 2020.ͥ While developed markets will remain important for biosimilars manufacturers, Deloitte analysis indicates that long-term growth may be fueled by emerging markets.

Medical products

Article

Identification of Medicinal Products

Think Transformation

About us

2017 Global Impact Report

Are you ready for industry 4.0?

Contact us

Contact us via our online form

Services

Deloitte UK Centre for Health Solutions

The health services research arm of Deloitte United Kingdom.
Deloitte U.S. Center for Health Solutions

The health services research arm of Deloitte United States.
Life sciences supply chain

Helping to optimize, reinvent and improve supply chains for companies across the pharmaceutical, biotechnology and medical device industries. Read to learn more.
Deloitte Analytics

Life Sciences and Healthcare Learn how Deloitte member firms are helping organizations link business strategy to advanced analytical techniques to improve decision-making capabilities.

Similar topics

Life Sciences

Greg Reh

Deloitte Global Life Sciences & Health Care Leader

grreh@deloitte.com

+1 215 977 7559

Get In Touch Author Host Panel

Follow us @DeloitteHealth

Join the conversation on Twitter

Contact us
Submit RFP
Job search

Get Connected

Newsroom
Home
Social media
Leadership blog
Press releases
Submit an RFP
Job Search
Global office directory
Contact us

Services

Audit & Assurance
Consulting
Risk Advisory
Financial Advisory
Legal
Tax

Industries

Consumer
Energy, Resources & Industrials
Financial Services
Government & Public Services
Life Sciences & Health Care
Technology, Media & Telecommunications

Careers

Job search
Experienced hires
Students
Life at Deloitte
Alumni

Legal

About Deloitte
Terms of use
Cookies
Privacy
Privacy Shield
Accessibility statement

© 2018. For information, contact Deloitte Touche Tohmatsu Limited.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.